Research, Development, And Testing Services - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Research, industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Research, Development, And Testing Services - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Research, Development, And Testing Services
Corporate Insider Buy Sell Ratio (Insider Count) - Research, Development, And Testing Services
Research, Development, And Testing Services - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2026-01-30 CRL / Charles River Laboratories International, Inc. 4 Creamer Victoria L F - Taxes D 211.68 -1,296
2026-01-30 CRL / Charles River Laboratories International, Inc. 4 Mintz Mark F - Taxes D 211.68 -655
2026-01-30 CRL / Charles River Laboratories International, Inc. 4 Knell Michael Gunnar F - Taxes D 211.68 -526
2026-01-30 CRL / Charles River Laboratories International, Inc. 4 Mintz Mark A - Award D 1,797
2026-01-30 CRL / Charles River Laboratories International, Inc. 4 Knell Michael Gunnar A - Award D 1,668
2026-01-30 CRL / Charles River Laboratories International, Inc. 4 Creamer Victoria L A - Award D 5,006
2026-01-30 CRL / Charles River Laboratories International, Inc. 4 LaPlume Joseph W A - Award D 5,456
2026-01-30 CRL / Charles River Laboratories International, Inc. 4 Parisotto Shannon M A - Award D 4,236
2026-01-30 CRL / Charles River Laboratories International, Inc. 4 FOSTER JAMES C A - Award D 39,031
2026-01-30 CRL / Charles River Laboratories International, Inc. 4 Girshick Birgit A - Award D 9,500
2026-01-28 IQV / IQVIA Holdings Inc. 4 Fedock Michael J. F - Taxes D 239.76 -381
2026-01-28 ABSI / Absci Corporation 4 Bedrick Todd A - Award D 15,000
2026-01-22 BUDZ / WEED, Inc. 4 BREEN NICOLE M Includes shares held by Nicole Breen and Ryan Breen (spouse) S - Sale I 0.0420 -38,000
2026-01-20 NEO / NeoGenomics, Inc. 4 Stone Warren S - Sale D 12.5037 -22,128
2026-01-20 INCY / Incyte Corporation 4 Morrissey Michael James F - Taxes D 102.62 -429
2026-01-16 INCY / Incyte Corporation 4 Morrissey Michael James A - Award D 7,426
2026-01-16 INCY / Incyte Corporation 4 Heeson Lee A - Award D 8,911
2026-01-13 NEO / NeoGenomics, Inc. 4 Olivo Alicia C M - Exercise D 59,382
2026-01-13 NEO / NeoGenomics, Inc. 4 Stone Warren M - Exercise D 59,382
2026-01-13 NEO / NeoGenomics, Inc. 4 Olivo Alicia C F - Taxes D -15,145
2026-01-13 NEO / NeoGenomics, Inc. 4 Stone Warren F - Taxes D -15,127
2026-01-07 INCY / Incyte Corporation 4 Issa Mohamed Khairie S - Sale D 109.07 -10,856
2026-01-06 INCY / Incyte Corporation 4 Issa Mohamed Khairie F - Taxes D 106.66 -8,264
2026-01-05 INCY / Incyte Corporation 4 Stein Steven H S - Sale D 101.70 -15,634
2026-01-05 NRC / NRC Health 4 Hays Michael D. M - Exercise D 15.23 9,145
2026-01-05 NRC / NRC Health 4 Burik David A - Award D 100,000
2025-12-31 MEDP / Medpace Holdings, Inc. 4 Kraft Robert O. M - Exercise D 56
2025-12-31 MEDP / Medpace Holdings, Inc. 4 Carley Brian T M - Exercise D 62
2025-12-31 MEDP / Medpace Holdings, Inc. 4 McCarthy Cornelius P. III M - Exercise D 49
2025-12-31 INCY / Incyte Corporation 4 Stein Steven H F - Taxes D 98.77 -13,292
2025-12-31 INCY / Incyte Corporation 4 Morrissey Michael James F - Taxes D 98.77 -254
2025-12-31 INCY / Incyte Corporation 4 Clancy Paul J A - Award D 98.77 241
2025-12-31 INCY / Incyte Corporation 4 BAKER BROS. ADVISORS LP See Footnotes A - Award I 328
2025-12-31 INCY / Incyte Corporation 4 BAKER BROS. ADVISORS LP See Footnotes A - Award I 328
2025-12-31 INCY / Incyte Corporation 4 HARRIGAN EDMUND A - Award D 98.77 245
2025-12-29 NRC / NRC Health 4 HARRISON SHANE R F - Taxes D 18.66 -21,271
2025-12-19 INCY / Incyte Corporation 4 Tray Thomas S - Sale D 100 -2,774
2025-12-19 INCY / Incyte Corporation 4 Tray Thomas M - Exercise D 95.76 1,044
2025-12-19 INCY / Incyte Corporation 4 Tray Thomas M - Exercise D 95.76 1,730
2025-12-18 INCY / Incyte Corporation 4 Tray Thomas S - Sale D 98.25 -600
2025-12-18 IQV / IQVIA Holdings Inc. 4 BOUSBIB ARI S - Sale D 222.43 -36,564
2025-12-18 IQV / IQVIA Holdings Inc. 4 BOUSBIB ARI M - Exercise D 59.90 50,000
2025-12-18 IQV / IQVIA Holdings Inc. 4 BOUSBIB ARI D - Sale to Issuer D 222.91 -13,436
2025-12-17 INCY / Incyte Corporation 4 Morrissey Michael James S - Sale D 97.26 -4,323
2025-12-16 INCY / Incyte Corporation 4 Morrissey Michael James S - Sale D 97.29 -53,175
2025-12-16 INCY / Incyte Corporation 4 Morrissey Michael James S - Sale D 97.42 -833
2025-12-15 NRC / NRC Health 4 Hrdy Helen M - Exercise D 15.23 12,346
2025-12-15 NRC / NRC Health 4 Hrdy Helen F - Taxes D 17.64 -11,244
2025-12-11 INCY / Incyte Corporation 4 Mayes Patrick A S - Sale D 94.94 -255
2025-12-10 INCY / Incyte Corporation 4 Mayes Patrick A S - Sale D 95.58 -5,553
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)